Sunday, March 1, 2026

TL;DR

Today’s briefing covers 12 items from 13 sources. Top stories include: Anthropic’s Claude rises to No. 2 in the App Store following Pentagon dispute; The billion-dollar infrastructure deals powering the AI boom; OpenAI’s Sam Altman announces Pentagon deal with ‘technical safeguards’.

Top Stories

Anthropic’s Claude rises to No. 2 in the App Store following Pentagon dispute

TechCrunch AI

Anthropic’s chatbot Claude seems to have benefited from the attention around the company’s fraught negotiations with the Pentagon.

The billion-dollar infrastructure deals powering the AI boom

TechCrunch AI

Here’s everything we know about the biggest AI infrastructure projects, including major spending from Meta, Oracle, Microsoft, Google, and OpenAI.

OpenAI’s Sam Altman announces Pentagon deal with ‘technical safeguards’

TechCrunch AI

OpenAI’s CEO claims its new defense contract includes protections addressing the same issues that became a flashpoint for Anthropic.

Who’s really running AI? Inside the billion-dollar battle over regulation with Alex Bores

TechCrunch AI

The Pentagon is playing chicken with Anthropic over who gets to control how the military uses AI while communities across the country are blocking data center construction. As the AI debate has been flattened to “doomers versus boomers,” one state legisla

OpenAI snags $110 billion in investments from Amazon, Nvidia, and Softbank

The Verge AI

OpenAI has closed another round of funding, totalling $110 billion being newly committed to the maker of ChatGPT, which it says has more than 900 million weekly active users and over 50 million consumer subscribers. Amazon is investing $50 billion and striking a deal that includes plans for custom m

Industry Updates

News & Analysis

Deep Dive: Today’s AI Landscape

Synthesized from multiple research sources

Several significant AI breakthroughs and announcements have emerged recently in early 2026:

Protein Design and Drug Discovery

Researchers at MIT have developed a generative AI model for protein-based drug design that predicts how synthetic proteins will fold and interact with biological targets with unprecedented accuracy.[1] This technology reduces the need for expensive laboratory testing and could accelerate treatments for cancer, autoimmune diseases, and rare genetic disorders while saving pharmaceutical companies billions in R&D costs.

Sources:

In the first six weeks of 2026 (up to early February), 17 US-based AI startups raised $100M+ in funding, with three exceeding $1B: SkildAI ($1.4B Series C), Flapping Airplanes ($180M seed at $1.5B valuation, but noted in billion-dollar context), and likely Anthropic or xAI based on patterns.[1][3]

Key Funding Deals in Early 2026

These deals highlight a surge in large rounds, driven by investor focus on AI infrastructure, models, and applications, with Nvidia frequently participating for GPU access.[1][3]

Sources:


This newsletter is automatically generated by PAI using RSS aggregation and AI research tools. Sources include arXiv, HuggingFace, OpenAI, Google AI, MIT News, VentureBeat, and more.

Have feedback? Reply to this post or reach out on X/Twitter.